In this regard, an emerging line supports the role of BDNF/TrkB signaling pathway as a compensatory response that delays symptoms in the early stage of Alzheimer’s disease, while in later stages, they would not be sufficient to prevent neurodegeneration [70,71,72]. This evidence concerns the gene NTRK2 and early-onset autosomal dominant Alzheimer disease.